Prolacta Bioscience is the pioneer in human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a privately held, scientifically driven company, committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Mothers who have a surplus of breast milk can help save the country's most fragile infants by donating their extra breast milk to one of Prolacta's affiliate milk banks.
New hires at Prolacta Bioscience
-
Director of Operations
Came from...
Aaron Industries, Inc, Vice President and General Manager
-
-
Prolacta Bioscience Activity on LinkedIn
-
Prolacta Bioscience An interesting study at Stanford University showed that a combination of electric pumping and hand expression helped preemie mom’s milk production produce more fat. http://scopeblog.stanford.edu/2012/01/more-nutritious-breast-milk-for-preemies/
